MicroRNA-128 inhibits the development of human colon cancer by targeting Rho family GTPase 3

References

• Zhao Y, Hu X, Zuo X, et al. Chemopreventive effects of some popular phytochemicals on human colon cancer: a review. Food Funct. 2018;9(9):4548–4568.
   PubMed Web of Science ®Google Scholar
• Zhang B, Fang C, Deng D, et al. Research progress on common adverse events caused by targeted therapy for colorectal cancer. Oncol Lett. 2018;16(1):27–33.
   PubMed Web of Science ®Google Scholar
• Benson AB, Venook AP, Cederquist L, et al. Colon cancer, version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Net. 2017;15(3):370–398.
   PubMed Web of Science ®Google Scholar
• Vannini I, Fanini F, Fabbri M. Emerging roles of microRNAs in cancer. Curr Opin Genet Dev. 2018;48:128–133.
   PubMed Web of Science ®Google Scholar
• Lan J, Huang Z, Han J, et al. Redox regulation of microRNAs in cancer. Cancer Lett. 2018;418:250–259.
   PubMed Web of Science ®Google Scholar
• Herranz H, Cohen SM. MicroRNAs and gene regulatory networks: managing the impact of noise in biological systems. Genes Dev. 2010;24(13):1339–1344.
   PubMed Web of Science ®Google Scholar
• Fabian MR, Sundermeier TR, Sonenberg N. Understanding how miRNAs post-transcriptionally regulate gene expression. InmiRNA regulation of the translational machinery. Berlin: Springer; 2010. p. 1–20.
   Google Scholar
• Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev. 2005;15(5):563–568.
   PubMed Web of Science ®Google Scholar
• Melo SA, Esteller M. Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett. 2011;585(13):2087–2099.
   PubMed Web of Science ®Google Scholar
• Shah MY, Calin GA. MicroRNAs as therapeutic targets in human cancers. Wiley Interdiscip Rev: RNA. 2014;5(4):537–548.
   PubMed Web of Science ®Google Scholar
• Wu L, Shi B, Huang K, et al. MicroRNA-128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1. Oncol Rep. 2015;34(5):2797–2805.
   PubMed Web of Science ®Google Scholar
• Zhao J, Li D, Fang L. MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1. Biomed Pharmacother. 2019;115:108947.
   PubMed Web of Science ®Google Scholar
• Guo Y, Yue P, Wang Y, et al. PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis. Biomed Pharmacother. 2019;118:109255.
   PubMed Web of Science ®Google Scholar
• Li B, Chen H, Wu N, et al. Deregulation of miR-128 in ovarian cancer promotes cisplatin resistance. Int J Gynecol Cancer. 2014;24:8.
   Web of Science ®Google Scholar
• Zhou XU, Qi L, Tong S, et al. miR-128 downregulation promotes growth and metastasis of bladder cancer cells and involves VEGF-C upregulation. Oncol Lett. 2015;10(5):3183–3190.
   PubMed Web of Science ®Google Scholar
• Shang C, Hong Y, Guo Y, et al. miR-128 regulates the apoptosis and proliferation of glioma cells by targeting RhoE. Oncol Lett. 2016;11(1):904–908.
   PubMed Web of Science ®Google Scholar
• Wolpin BM, Mayer RJ. Systemic treatment of colorectal cancer. Gastroenterology. 2008;134(5):1296–1310.
   PubMed Web of Science ®Google Scholar
• Osman A. MicroRNAs in health and disease–basic science and clinical applications. Clin Lab. 2012;58(5–6):393.
   PubMed Web of Science ®Google Scholar
• Ors-Kumoglu G, Gulce-Iz S, Biray-Avci C. Therapeutic microRNAs in human cancer. Cytotechnology. 2019;71(1):411–425.
   PubMed Web of Science ®Google Scholar
• Chen PS, Su JL, Hung MC. Dysregulation of microRNAs in cancer. J Biomed Sci. 2012;19(1):1–8.
   PubMedGoogle Scholar
• Jin M, Zhang T, Liu C, et al. miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells. Cancer Res. 2014;74(15):4183–4195.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhao D, Meng Q. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer. Biomed Pharmacother. 2019;116:108966.
   PubMed Web of Science ®Google Scholar
• Zhao L, Li R, Xu S, et al. Tumor suppressor miR-128-3p inhibits metastasis and epithelial–mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer. Acta Biochim Biophys Sin. 2018;50(2):171–180.
   Google Scholar
• Zhao D, Han W, Liu X, et al. Micro RNA-128 promotes apoptosis in lung cancer by directly targeting NIMA-related kinase 2. Thorac Cancer. 2017;8(4):304–311.
   PubMed Web of Science ®Google Scholar
• Cui J, Zhao Y, Sethi P, et al. Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation. J Neuro-Oncol. 2010;98(3):297–304.
   PubMed Web of Science ®Google Scholar
• Paysan L, Piquet L, Saltel F, et al. Rnd3 in cancer: a review of the evidence for tumor promoter or suppressor. Mol Cancer Res. 2016;14(11):1033–1044.
   PubMed Web of Science ®Google Scholar